| Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions R De Alwis, SA Smith, NP Olivarez, WB Messer, JP Huynh, ... Proceedings of the National Academy of Sciences 109 (19), 7439-7444, 2012 | 472 | 2012 |
| In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection R de Alwis, M Beltramello, WB Messer, S Sukupolvi-Petty, WMPB Wahala, ... PLoS neglected tropical diseases 5 (6), e1188, 2011 | 261 | 2011 |
| A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins G Fibriansah, JL Tan, SA Smith, R De Alwis, TS Ng, VA Kostyuchenko, ... Nature communications 6 (1), 6341, 2015 | 217 | 2015 |
| Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset S Kalimuddin, CYL Tham, M Qui, R de Alwis, JXY Sim, JME Lim, HC Tan, ... Med 2 (6), 682-688. e4, 2021 | 204 | 2021 |
| Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera R De Alwis, KL Williams, MA Schmid, CY Lai, B Patel, SA Smith, ... PLoS pathogens 10 (10), e1004386, 2014 | 203 | 2014 |
| A potent anti‐dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface G Fibriansah, JL Tan, SA Smith, AR de Alwis, TS Ng, VA Kostyuchenko, ... EMBO molecular medicine 6 (3), 358-371, 2014 | 197 | 2014 |
| Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development R De Alwis, S Chen, ES Gan, EE Ooi EBioMedicine 55, 2020 | 172 | 2020 |
| A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice R De Alwis, ES Gan, S Chen, YS Leong, HC Tan, SL Zhang, C Yau, ... Molecular Therapy 29 (6), 1970-1983, 2021 | 171 | 2021 |
| Natural strain variation and antibody neutralization of dengue serotype 3 viruses WMPB Wahala, EF Donaldson, R de Alwis, MA Accavitti-Loper, RS Baric, ... PLoS pathogens 6 (3), e1000821, 2010 | 168 | 2010 |
| The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein SA Smith, AR de Alwis, N Kose, E Harris, KD Ibarra, KM Kahle, JM Pfaff, ... MBio 4 (6), 10.1128/mbio. 00873-13, 2013 | 164 | 2013 |
| RETRACTED: Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity WB Messer, R De Alwis, BL Yount, SR Royal, JP Huynh, SA Smith, ... Proceedings of the National Academy of Sciences 111 (5), 1939-1944, 2014 | 134 | 2014 |
| Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals AT Tan, JME Lim, N Le Bert, K Kunasegaran, A Chia, MDC Qui, N Tan, ... The Journal of clinical investigation 131 (17), 2021 | 111 | 2021 |
| Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional … SA Smith, AR de Alwis, N Kose, RS Jadi, AM de Silva, JE Crowe Jr Journal of virology 88 (21), 12233-12241, 2014 | 101 | 2014 |
| Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics SA Smith, R De Alwis, N Kose, AP Durbin, SS Whitehead, AM De Silva, ... The Journal of infectious diseases 207 (12), 1898-1908, 2013 | 89 | 2013 |
| Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype R de Alwis, DJ Bangs, MA Angelo, C Cerpas, A Fernando, J Sidney, ... Journal of virology 90 (9), 4771-4779, 2016 | 78 | 2016 |
| Dengue virus prM-specific human monoclonal antibodies with virus replication-enhancing properties recognize a single immunodominant antigenic site SA Smith, UK Nivarthi, R de Alwis, N Kose, G Sapparapu, R Bombardi, ... Journal of virology 90 (2), 780-789, 2016 | 60 | 2016 |
| Differential immunogenicity of homologous versus heterologous boost in Ad26. COV2. S vaccine recipients NKH Khoo, JME Lim, US Gill, R de Alwis, N Tan, JZN Toh, JE Abbott, ... Med 3 (2), 104-118. e4, 2022 | 53 | 2022 |
| A cross-sectional seroepidemiological survey of typhoid fever in Fiji CH Watson, S Baker, CL Lau, K Rawalai, M Taufa, J Coriakula, ... PLoS neglected tropical diseases 11 (7), e0005786, 2017 | 52 | 2017 |
| No clinical benefit of empirical antimicrobial therapy for pediatric diarrhea in a high-usage, high-resistance setting VT Duong, HT Tuyen, P Van Minh, JI Campbell, HL Phuc, TDH Nhu, ... Clinical Infectious Diseases 66 (4), 504-511, 2018 | 47 | 2018 |
| Functional transplant of a dengue virus serotype 3 (DENV3)-specific human monoclonal antibody epitope into DENV1 WB Messer, BL Yount, SR Royal, R de Alwis, DG Widman, SA Smith, ... Journal of virology 90 (10), 5090-5097, 2016 | 40 | 2016 |
James CroweVanderbilt University Medical CenterE-mailová adresa ověřena na: vanderbilt.edu
